Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433)
Abstract Targeted delivery of drugs to the brain is challenging due to the restricted permeability across the blood brain barrier (BBB). Gliomas are devastating cancers and their positive treatment outcome using Temozolomide (TMZ) is limited due to its short plasma half-life, systemic toxicity and l...
Enregistré dans:
Auteurs principaux: | Sonali Kumari, Saad M. Ahsan, Jerald M. Kumar, Anand K. Kondapi, Nalam M. Rao |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/183749ab737e48c48f272de1318a8a76 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy
par: Zhang J, et autres
Publié: (2018) -
Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma
par: Shi H, et autres
Publié: (2020) -
Temozolomide arrests glioma growth and normalizes intratumoral extracellular pH
par: Jyotsna U. Rao, et autres
Publié: (2017) -
Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment
par: Peng Y, et autres
Publié: (2018) -
Temozolomide is additive with cytotoxic effect of irradiation in canine glioma cell lines
par: Nina Simona Tresch, et autres
Publié: (2021)